Home » Topics » BioWorld Science

BioWorld Science
RSS

AstraZeneca initiates phase I/IIa study of AZD-7648 alone and in combination for advanced cancers

Nov. 5, 2019

Promising preclinical results presented for DTX-701, a gene therapy for Wilson disease

Nov. 5, 2019

VRN-071961: a potent EGFR kinase inhibitor active in Ex20Ins EGFR mutation-driven NSCLC

Nov. 5, 2019

Novartis presents phase II data for QBW-276

Nov. 5, 2019

Preclinical data for SNSP-113 support its development as new approach to treat mucus stasis in CF

Nov. 5, 2019

KYM-003, potent and selective STAT3 degrader with strong antitumor activity in vivo

Nov. 5, 2019

Development of novel PRKACA inhibitors for the treatment of fibrolamellar carcinoma

Nov. 5, 2019

Positive interim safety and efficacy data presented for OTS Allocetra

Nov. 5, 2019

Harbour BioMed initiates first-in-human study of HBM-4003

Nov. 5, 2019

FDA approves Talicia for treatment of H. pylori in adults

Nov. 5, 2019

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...